EI
NEO icon

Ellevest Inc’s NeoGenomics NEO Stock Holding History

Ellevest Inc’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-310
Closed -$5.4K – 1170
2023
Q1 		$5.4K Buy
310
+147
+90% +$2.09K ﹤0.01% 1182
2022
Q4 		$1.51K Sell
163
-73
-31% -$681 ﹤0.01% 1432
2022
Q3 		$2K Buy
+236
New +$2.34K ﹤0.01% 1355
2022
Q2 		– Sell
-6
Closed – – 1577
2022
Q1 		$0 Buy
+6
New +$126 ﹤0.01% 1556
2021
Q2 		– Sell
-39
Closed -$2K – 1359
2021
Q1 		$2K Buy
39
+13
+50% +$677 ﹤0.01% 1070
2020
Q4 		$1K Buy
+26
New +$1.18K ﹤0.01% 1086

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ellevest Inc's NEO Position: Q2 2023 in Review

Ellevest Inc sold out of NeoGenomics (NEO) in Q2 2023, closing a stake of 310 shares — an estimated $5.4K sold.

Ellevest Inc first reported a position in NEO in Q4 2020 and held it in 6 quarters. The position peaked at $5.4K in Q1 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2023.

  • Ellevest Inc reported no remaining NeoGenomics position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 310 NeoGenomics shares in Q2 2023, an estimated $5.4K.
  • Ellevest Inc first reported a position in NeoGenomics in Q4 2020 and held it in 6 quarters.
  • Ellevest Inc's NeoGenomics position peaked at $5.4K in Q1 2023.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.